Literature DB >> 24294365

The correlation between morphology and the expression of TGF-β signaling pathway proteins and epithelial-mesenchymal transition-related proteins in synovial sarcomas.

Yan Qi1, Cui-Cui Wang, Yong-Lai He, Hong Zou, Chun-Xia Liu, Li-Juan Pang, Jian-Ming Hu, Jin-Fang Jiang, Wen-Jie Zhang, Feng Li.   

Abstract

Synovial sarcoma (SS) is a malignant tumor of soft tissue and is noted for late local recurrence and metastasis. Aberrant epithelial-mesenchymal transition (EMT) has been implicated in the pathogenesis of diverse human malignancies. Immunohistochemical techniques were used to assess EMT-related proteins (E-cadherin, N-cadherin, β-catenin, Snail, and Slug) and the TGF-β1 pathway (TGF-β1 and Smad2/3) proteins expression in different histological subtypes and epithelial mesenchymal compositions of SS. The expression of cell-surface (E-cadherin) and cytoskeletal proteins (β-catenin) were higher significantly in biphasic SSs (BSSs) (70.4%, 51.9%) than MFSSs (both for 10%). Among monophasic fibrous SSs (MFSSs) samples, E-cadherin protein expression was negatively correlated with expression Snail, Slug, TGF-β1, and Smad2/3. The expression levels of Snail and Smad2/3 were correlated with the pTNM stage (I-II vs. III-IV; P=0.047, P=0.021) and TGF-β1 exhibited a tendency toward a positive correlation with pTNM stage (I-II vs. III-IV; P=0.052), but did not correlate with the histological grade (p>0.05). Interestingly, our data showed that expression of E-cadherin protein correlated with greater survival in SS patients. Overexpression of Snail, and TGF-β1 is associated with suppressed expression of E-cadherin in MFSSs, which supports the hypothesis that the MFSS subtype may have developed via neoplastic EMT.

Entities:  

Keywords:  Synovial sarcomas; TGF-β1 signaling pathway; epithelial-mesenchymal transition; immunohistochemistry

Mesh:

Substances:

Year:  2013        PMID: 24294365      PMCID: PMC3843259     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  34 in total

Review 1.  Crosstalk between TGF-β and hedgehog signaling in cancer.

Authors:  Delphine Javelaud; Marie-Jeanne Pierrat; Alain Mauviel
Journal:  FEBS Lett       Date:  2012-05-15       Impact factor: 4.124

Review 2.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 3.  Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma.

Authors:  C S Scanlon; E A Van Tubergen; R C Inglehart; N J D'Silva
Journal:  J Dent Res       Date:  2012-11-05       Impact factor: 6.116

4.  Garcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer cells.

Authors:  Aamir Ahmad; Sanila H Sarkar; Bassam Bitar; Shadan Ali; Amro Aboukameel; Seema Sethi; Yiwei Li; Bin Bao; Dejuan Kong; Sanjeev Banerjee; Subhash B Padhye; Fazlul H Sarkar
Journal:  Mol Cancer Ther       Date:  2012-07-19       Impact factor: 6.261

5.  The SLUG zinc-finger protein represses E-cadherin in breast cancer.

Authors:  Karen M Hajra; David Y-S Chen; Eric R Fearon
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

6.  Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells.

Authors:  Julia Schulte; Michaela Weidig; Philipp Balzer; Petra Richter; Marcus Franz; Kerstin Junker; Mieczyslaw Gajda; Karlheinz Friedrich; Heiko Wunderlich; Arne Östman; Iver Petersen; Alexander Berndt
Journal:  Histochem Cell Biol       Date:  2012-07-22       Impact factor: 4.304

7.  Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.

Authors:  Toni Celià-Terrassa; Oscar Meca-Cortés; Francesca Mateo; Alexia Martínez de Paz; Nuria Rubio; Anna Arnal-Estapé; Brian J Ell; Raquel Bermudo; Alba Díaz; Marta Guerra-Rebollo; Juan José Lozano; Conchi Estarás; Catalina Ulloa; Daniel Álvarez-Simón; Jordi Milà; Ramón Vilella; Rosanna Paciucci; Marian Martínez-Balbás; Antonio García de Herreros; Roger R Gomis; Yibin Kang; Jerónimo Blanco; Pedro L Fernández; Timothy M Thomson
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

8.  Immunohistochemical study of correlation between histologic subtype and expression of epithelial-mesenchymal transition-related proteins in synovial sarcomas.

Authors:  Manish Mani Subramaniam; Samuel Navarro; Antonio Llombart-Bosch
Journal:  Arch Pathol Lab Med       Date:  2011-08       Impact factor: 5.534

Review 9.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

10.  Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation.

Authors:  Mei-Yi Lee; Cheng-Yang Chou; Ming-Jer Tang; Meng-Ru Shen
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

View more
  9 in total

1.  Prognostic role of upregulated P300 expression in human cancers: A clinical study of synovial sarcoma and a meta-analysis.

Authors:  Zihan Liu; Yonglai He; Xiaojuan Lian; Hong Zou; Yalan Huang; Ning Wang; Jianming Hu; Xiaobin Cui; Jin Zhao; Wenjie Zhang; Wenyi Gu; Lijuan Pang; Yan Qi
Journal:  Exp Ther Med       Date:  2019-08-16       Impact factor: 2.447

2.  REDD1 and p-AKT over-expression may predict poor prognosis in ovarian cancer.

Authors:  Wei Jia; Bin Chang; Lili Sun; Huimin Zhu; Lijuan Pang; Lin Tao; Hong Zou; Jinze Du; Yuling Dong; Yan Qi; Jinfang Jiang; Weihua Liang; Feng Li; Xia Zhao
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  Overexpression of GEFT, a Rho family guanine nucleotide exchange factor, predicts poor prognosis in patients with rhabdomyosarcoma.

Authors:  Chao Sun; Chunxia Liu; Shugang Li; Hongan Li; Yuanyuan Wang; Yuwen Xie; Bingcheng Li; Xiaobin Cui; Yunzhao Chen; Wenjie Zhang; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

4.  Down-regulated E-cadherin expression is associated with poor five-year overall survival in bone and soft tissue sarcoma: results of a meta-analysis.

Authors:  Ning Wang; Yong-Lai He; Li-Juan Pang; Hong Zou; Chun-Xia Liu; Jin Zhao; Jian-Ming Hu; Wen-Jie Zhang; Yan Qi; Feng Li
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

5.  Transforming growth factor-β1 signaling promotes epithelial-mesenchymal transition-like phenomena, cell motility, and cell invasion in synovial sarcoma cells.

Authors:  Yan Qi; Ning Wang; Yonglai He; Jun Zhang; Hong Zou; Wenjie Zhang; Wenyi Gu; Yalan Huang; Xiaojuan Lian; Jianming Hu; Jin Zhao; Xiaobin Cui; Lijuan Pang; Feng Li
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

6.  Overexpression of carbonyl reductase 1 inhibits malignant behaviors and epithelial mesenchymal transition by suppressing TGF-β signaling in uterine leiomyosarcoma cells.

Authors:  Takuya Kajimura; Shun Sato; Akihiro Murakami; Maki Hayashi-Okada; Kengo Nakashima; Kotaro Sueoka; Norihiro Sugino
Journal:  Oncol Lett       Date:  2019-05-31       Impact factor: 2.967

7.  Identification of potential mutations and genomic alterations in the epithelial and spindle cell components of biphasic synovial sarcomas using a human exome SNP chip.

Authors:  Yan Qi; Ning Wang; Li-Juan Pang; Hong Zou; Jian-Ming Hu; Jin Zhao; Jun Zhang; Chun-Xia Liu; Wen-Jie Zhang; Xiang-Lin Yuan; Feng Li
Journal:  BMC Med Genomics       Date:  2015-10-27       Impact factor: 3.063

8.  SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.

Authors:  Changliang Peng; Hui Zhao; Yan Song; Wei Chen; Xiaoying Wang; Xiaoli Liu; Cheng Zhang; Jie Zhao; Ji Li; Guanghui Cheng; Dongjin Wu; Chunzheng Gao; Xiuwen Wang
Journal:  J Exp Clin Cancer Res       Date:  2017-10-11

Review 9.  Molecular mechanisms underpinning sarcomas and implications for current and future therapy.

Authors:  Victoria Damerell; Michael S Pepper; Sharon Prince
Journal:  Signal Transduct Target Ther       Date:  2021-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.